These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1042 related articles for article (PubMed ID: 3114621)

  • 21. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes.
    Fuchshuber PR; Lotzová E; Pollock RE
    Lymphokine Cytokine Res; 1991 Apr; 10(1-2):51-9. PubMed ID: 1651770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R; Nagler A
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant interleukin-2-activated intracavitary lymphocytes: phenotypic characteristics and effector function.
    Umiel T; Monselise J; Klein T; Rakovsky E; Fenig E; Lurie H; Adler A
    J Biol Response Mod; 1989 Aug; 8(4):409-21. PubMed ID: 2787838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
    Thiele DL; Patel SS; Lipsky PE
    J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
    Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J; Gulati SC
    Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation.
    Preffer FI; Colvin RB; Leary CP; Boyle LA; Tuazon TV; Lazarovits AI; Cosimi AB; Kurnick JT
    J Immunol; 1986 Nov; 137(9):2823-30. PubMed ID: 3093583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.
    Vie H; Bonneville M; Sondermeyer P; Moreau JF; Soulillou JP
    Immunology; 1986 Mar; 57(3):351-7. PubMed ID: 3082744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.
    Bensussan A; Lagabrielle JF; Castaigne S; Boisson N; Miclea JM; Benbunan M; Degos L
    Nouv Rev Fr Hematol (1978); 1989; 31(2):129-32. PubMed ID: 2528119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of natural killer effectors from human thymus with recombinant IL-2.
    Michon JM; Caligiuri MA; Hazanow SM; Levine H; Schlossman SF; Ritz J
    J Immunol; 1988 May; 140(10):3660-7. PubMed ID: 3258886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes.
    Schwarz RE; Hiserodt JC
    J Immunol; 1988 Nov; 141(10):3318-23. PubMed ID: 3263421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells.
    Itoh K; Platsoucas CD; Tilden AB; Pollock RE; Balch CM
    Cell Immunol; 1987 Sep; 108(2):283-96. PubMed ID: 3113741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS; Thiele DL; Lipsky PE
    J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a lipid-like cytotoxin from human CD16+ natural killer cells.
    Cosentino LM; Cathcart MK
    Cancer Res; 1989 Dec; 49(23):6662-9. PubMed ID: 2531033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.